<DOC>
	<DOCNO>NCT00855517</DOCNO>
	<brief_summary>The purpose study evaluate IOP response experimental dose Latanoprost- PPDS subject ocular hypertension open-angle glaucoma .</brief_summary>
	<brief_title>A Phase 2 Study Latanoprost Punctal Plug Delivery System Subjects With Ocular Hypertension Open-Angle Glaucoma</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Latanoprost</mesh_term>
	<criteria>Over 18 yrs age ocular hypertension openangle glaucoma Subjects best correct visual acuity 20/100 good Subjects wear contact lens . Uncontrolled medical condition Subjects require chronic topical artifical tear , lubricant and/or require chronic topical medication Subjects history chronic recurrent inflammatory eye disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
</DOC>